Log In
BCIQ
Print this Print this
 

Invossa, TissueGene-C (TG-C)

  Manage Alerts
Collapse Summary General Information
Company TissueGene Inc.
DescriptionFixed-ratio mixture of non-transduced allogeneic human chondrocytes and allogeneic human chondrocytes expressing transforming growth factor (TGF) beta 1 (TGFB1)
Molecular Target Transforming growth factor (TGF) beta 1 (TGFB1)
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$434.2M

$23.8M

$410.4M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/01/2016

$434.2M

$23.8M

$410.4M

Get a free BioCentury trial today